The USPSTF changed its position on PSA testing, so where does that leave active surveillance?

Howard Wolinsky a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. In an ongoing series of articles for MedPage Today, he describes his journey from diagnosis to the decision to chose active surveillance. In this latest installment, he pursues the possibility that a change in USPSTF recommendations could mean a change for him.

I am one of the lucky ones. My prostate cancer has only been seen once in five biopsies over seven years. My urologist says I have a “lame cancer.” I can live with that.

In that single needle biopsy in November 2010, a 1-millimeter slice of cancer was found. I was diagnosed with a Gleason 3+3. That cancer has never been seen since, though it sends signals via PSA.

One of my urologists described me as…